229 related articles for article (PubMed ID: 24715704)
1. Sodium channel blockers for cystic fibrosis.
Burrows EF; Southern KW; Noone PG
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD005087. PubMed ID: 24715704
[TBL] [Abstract][Full Text] [Related]
2. Sodium channel blockers for cystic fibrosis.
Burrows EF; Southern KW; Noone PG
Cochrane Database Syst Rev; 2012 Mar; (3):CD005087. PubMed ID: 22419304
[TBL] [Abstract][Full Text] [Related]
3. Sodium channel blockers for cystic fibrosis.
Burrows E; Southern KW; Noone P
Cochrane Database Syst Rev; 2006 Jul; (3):CD005087. PubMed ID: 16856076
[TBL] [Abstract][Full Text] [Related]
4. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
[TBL] [Abstract][Full Text] [Related]
5. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM; Smith S
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001506. PubMed ID: 37319354
[TBL] [Abstract][Full Text] [Related]
6. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
[TBL] [Abstract][Full Text] [Related]
7. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
[TBL] [Abstract][Full Text] [Related]
8. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Southern KW; Solis-Moya A; Kurz D; Smith S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
[TBL] [Abstract][Full Text] [Related]
9. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
[TBL] [Abstract][Full Text] [Related]
10. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee TW; Southern KW; Perry LA; Penny-Dimri JC; Aslam AA
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005599. PubMed ID: 27314455
[TBL] [Abstract][Full Text] [Related]
11. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
12. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
[TBL] [Abstract][Full Text] [Related]
13. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
McIlwaine M; Button B; Dwan K
Cochrane Database Syst Rev; 2015 Jun; (6):CD003147. PubMed ID: 26083308
[TBL] [Abstract][Full Text] [Related]
14. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Bhatt J; Jahnke N; Smyth AR
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
[TBL] [Abstract][Full Text] [Related]
15. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Carter B; Putman M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD008901. PubMed ID: 30557452
[TBL] [Abstract][Full Text] [Related]
16. Dornase alfa for cystic fibrosis.
Yang C; Chilvers M; Montgomery M; Nolan SJ
Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
[TBL] [Abstract][Full Text] [Related]
17. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J; Nevitt SJ
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
[TBL] [Abstract][Full Text] [Related]
18. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
McIlwaine M; Button B; Nevitt SJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31774149
[TBL] [Abstract][Full Text] [Related]
19. Short-acting inhaled bronchodilators for cystic fibrosis.
Smith S; Rowbotham NJ; Edwards CT
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013666. PubMed ID: 35749226
[TBL] [Abstract][Full Text] [Related]
20. Exercise versus airway clearance techniques for people with cystic fibrosis.
Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
